Clinical Trial

Circulating Markers for Ischemic Heart Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2008-09-26; most recent amendment 2025-08-10.
Trial Details
NCT Number NCT00762333
Lead Sponsor UConn Health
Conditions Myocardial Infarction, Ischemia, Congestive Heart Failure
Enrollment 550 participants
Start Date 2007-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-08-12